Alnylam Act® Acute Hepatic Porphyria Sponsored Testing Program

No-charge genetic testing and counseling program

Alnylam Pharmaceuticals and PreventionGenetics have partnered to offer genetic testing and counseling for patients pubescent and older who may carry a gene mutation known to be associated with the acute hepatic porphyrias.

The Alnylam Act® program was created to provide access to genetic testing and counseling to patients as a way to help people make more informed decisions about their health.

Learn more on the Preventive Genetics website at the link below.